Central Garden (CENT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Central Garden (CENT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Central Garden & Pet Company (NASDAQ: CENT).
Upgrades * Morgan Stanley changed the rating for Paychex Inc (NASDAQ: PAYX) from Underweight to Equal-Weight. Paychex earned $0.70 in the second quarter, compared to $0.65 in the year-ago quarter. The stock has a 52-week-high of $90.53 and a 52-week-low of $54.48. Paychex's stock last closed at $60.79 per share. * BTIG changed the rating for Globus Medical Inc (NYSE: GMED) from Neutral to Buy. In the fourth quarter, Globus Medical showed an EPS of $0.49, compared to $0.43 from the year-ago quarter. The stock has a 52-week-high of $60.15 and a 52-week-low of $33.41. Globus Medical's stock last closed at $39.97 per share. * Susquehanna changed the rating for MGM Resorts International (NYSE: MGM) from Negative to Neutral. In the fourth quarter, MGM Resorts Intl earned $0.08. The stock has a 52-week-high of $34.63 and a 52-week-low of $9.00. MGM Resorts Intl's stock last closed at $9.54 per share. * B of A Securities changed the rating for Central Garden & Pet Co (NASDAQ: CENT) from Neutral to Buy. In the first quarter, Central Garden & Pet showed an EPS of ($0.08), compared to $0.03 from the year-ago quarter. The stock has a 52-week-high of $34.69 and a 52-week-low of $22.40. Central Garden & Pet's stock last closed at $29.65 per share. * For The Hershey Co (NYSE: HSY), Credit Suisse upgraded the stock from Neutral to Outperform. For the fourth quarter, Hershey had an EPS of $1.28, compared to year-ago quarter EPS of $1.26. The stock has a 52-week-high of $162.20 and a 52-week-low of $108.95. Hershey's stock last closed at $138.94 per share. * UBS changed the rating for Caterpillar Inc (NYSE: CAT) from Sell to Neutral. For the fourth quarter, Caterpillar had an EPS of $2.63, compared to year-ago quarter EPS of $2.55. The stock has a 52-week-high of $150.55 and a 52-week-low of $87.50. Caterpillar's stock last closed at $100.20 per share. * Dougherty & Co. changed the rating for NextGen Healthcare Inc (NASDAQ: NXGN) from Neutral to Buy. In the third quarter, NextGen Healthcare showed an EPS of $0.23, compared to $0.20 from the year-ago quarter. The stock has a 52-week-high of $21.12 and a 52-week-low of $5.10. NextGen Healthcare's stock last closed at $6.15 per share. * For Change Healthcare Inc (NASDAQ: CHNG), Raymond James upgraded the stock from Outperform to Strong Buy. Interestingly, in the third quarter, Change Healthcare's EPS was $0.33. The stock has a 52-week-high of $17.57 and a 52-week-low of $6.67. Change Healthcare's stock last closed at $7.78 per share. Downgrades * Morgan Stanley changed the rating for Monster Beverage Corp (NASDAQ: MNST) from Overweight to Equal-Weight. For the fourth quarter, Monster Beverage had an EPS of $0.47, compared to year-ago quarter EPS of $0.43. The stock has a 52-week-high of $70.52 and a 52-week-low of $52.23. Monster Beverage's stock last closed at $59.74 per share. * B. Riley FBR downgraded the stock for Sinclair Broadcast Group Inc (NASDAQ: SBGI) from Buy to Neutral. Sinclair Broadcast Group earned $0.94 in the fourth quarter, compared to $2.13 in the year-ago quarter. The stock has a 52-week-high of $66.57 and a 52-week-low of $10.94. Sinclair Broadcast Group's stock last closed at $13.54 per share.See more from Benzinga * Recap: Qutoutiao Q4 Earnings * Contura Energy: Q4 Earnings Insights * 11 Technology Stocks Moving In Wednesday's Pre-Market Session(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Central Garden (CENTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Central Garden (CENTA) delivered earnings and revenue surprises of 33.33% and 2.23%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Central Garden & Pet's (CENT) second-quarter fiscal 2020 performance has most likely been aided by higher organic sales and contributions from acquisitions.
"I have been following Dr. Inan Dogan since this outbreak, and he is a phenomenally intelligent researcher. One month ago, Dr. Dogan's prediction that the total U.S. death toll would be 20,000+ by April 15th was deemed "radical". His Recession is Imminent article in February was very timely. Now he believes we could quickly end […]
Pennington to partner with Habitat for Humanity in celebration of its 75th anniversary
With me on the call today are Tim Cofer, Central's Chief Executive Officer; Niko Lahanas, Chief Financial Officer; J.D. Walker, President, Garden Branded Business; and John Hanson, President, Pet Consumer Products. Good afternoon everyone and thank you for joining our Q2 earnings call.
Central Garden (CENT) delivered earnings and revenue surprises of 2.63% and 1.45%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Central Garden (CENTA) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Central Garden & Pet Q2 Sales increased 4.4% to $703.2M
Central Garden & Pet to Announce Q2'20 Earnings on Wednesday, May 6 after market
SunTrust Robinson analyst William Chappell maintained a Hold rating on Central Garden & Pet on Thursday, setting a price target of $35, which is approximately 2.59% below the present share price of $35.93.
Central Garden (CENTA) delivered earnings and revenue surprises of 5.41% and 1.45%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Central Garden (CENT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 2 (Buy).
Central Garden (CENTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Central Garden & Pet's (CENT) Q2 results benefit from acquisition-related gains, lower costs and solid growth in the Pet Segment. However, it withdraws fiscal 2020 view on COVID-19 impacts.